Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer (vol 76, pg 2301, 2016)

被引：0
|
作者：
Herrera-Abreu, Maria Teresa
Palafox, Marta
Asghar, Uzma
Rivas, Martin A.
Cutts, Rosalind J.
Garcia-Murillas, Isaac
Pearson, Alex
Guzman, Marta
Rodriguez, Olga
Grueso, Judit
Bellet, Meritxell
Cortes, Javier
Elliott, Richard
Pancholi, Sunil
Lord, Christopher J. [1 ,2 ]
Baselga, Jose
Dowsett, Mitch
Martin, Lesley-Ann
Turner, Nicholas C.
Serra, Violeta
机构：
[1] Inst Canc Res, CRUK Gene Funct Lab, London, England
[2] Inst Canc Res, Breast Canc Now Res Ctr, London, England
来源：
CANCER RESEARCH | 2016年 / 76卷 / 19期
关键词：
D O I：
10.1158/0008-5472.CAN-16-1853
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5907 / 5907
页数：1
相关论文
共 50 条
  • [1] Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer
    Herrera-Abreu, Maria Teresa
    Palafox, Marta
    Asghar, Uzma
    Rivas, Martin A.
    Cutts, Rosalind J.
    Garcia-Murillas, Isaac
    Pearson, Alex
    Guzman, Marta
    Rodriguez, Olga
    Grueso, Judit
    Bellet, Meritxell
    Cortes, Javier
    Elliott, Richard
    Pancholi, Sunil
    Baselga, Jose
    Dowsett, Mitch
    Martin, Lesley-Ann
    Turner, Nicholas C.
    Serra, Violeta
    CANCER RESEARCH, 2016, 76 (08) : 2301 - 2313
  • [2] Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
    Scheidemann, Erin R.
    Shajahan-Haq, Ayesha N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [3] Overcoming resistance to inhibitors of CDK4/6 and BET in estrogen receptor-positive breast cancer
    Cosin, Marc
    Tian, Tian
    Oliveros, Winona
    Kharenko, Olesya A.
    van der Horst, Edward H.
    Patel, Reena G.
    Calosing, Cyrus
    Campeau, Eric
    Jahagirdar, Ravi
    Lakhotia, Sanjay
    Mele, Marta
    Palafox, Marta
    Arribas, Joaquin
    Oliveira, Mafalda
    Saura, Cristina
    Serra, Violeta
    Peiro, Sandra
    CANCER RESEARCH, 2020, 80 (16)
  • [4] Willingness of women with early estrogen receptor-positive breast cancer to take adjuvant CDK4/6 inhibitors
    Lipton, N. J.
    Jesin, J.
    Warner, E.
    Cao, X.
    Kiss, A.
    Desautels, D.
    Jerzak, K. J.
    CURRENT ONCOLOGY, 2020, 27 (03) : 127 - 134
  • [5] Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor-Positive Breast Cancers
    Pesch, Andrea M.
    Hirsh, Nicole H.
    Chandler, Benjamin C.
    Michmerhuizen, Anna R.
    Ritter, Cassandra L.
    Androsiglio, Marlie P.
    Wilder-Romans, Kari
    Liu, Meilan
    Gersch, Christina L.
    Larios, Jose M.
    Pierce, Lori J.
    Rae, James M.
    Speers, Corey W.
    CLINICAL CANCER RESEARCH, 2020, 26 (24) : 6568 - 6580
  • [6] Mdm2 inhibition synergises with endocrine therapy or cdk4/6 inhibition for the treatment of estrogen receptor-positive breast cancer
    Portman, Neil
    Milioli, Heloisa
    Alexandrou, Sarah
    Coulson, Rhiannon
    Yong, Aliza
    Fernandez, Kristine
    Chia, KeeMing
    Halilovic, Ensar
    Segara, Davendra
    Parker, Andrew
    Haupt, Sue
    Haupt, Ygal
    Tilley, Wayne
    Swarbrick, Alex
    Caldon, Liz
    Lim, Elgene
    CANCER RESEARCH, 2021, 81 (04)
  • [7] CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective
    Zhou, Fiona H.
    Downton, Teesha
    Freelander, Allegra
    Hurwitz, Joshua
    Caldon, C. Elizabeth
    Lim, Elgene
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [8] CDK4/6 inhibitors in advanced hormone receptor-positive breast cancer
    Barroso-Sousa, Romualdo
    Tolaney, Sara M.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S205 - S209
  • [9] Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
    Glaviano, Antonino
    Wander, Seth A.
    Baird, Richard D.
    Yap, Kenneth C. -H.
    Lam, Hiu Yan
    Toi, Masakazu
    Carbone, Daniela
    Geoerger, Birgit
    Serra, Violeta
    Jones, Robert H.
    Ngeow, Joanne
    Toska, Eneda
    Stebbing, Justin
    Crasta, Karen
    Finn, Richard S.
    Diana, Patrizia
    Vuina, Karla
    de Bruin, Robertus A. M.
    Surana, Uttam
    Bardia, Aditya
    Kumar, Alan Prem
    DRUG RESISTANCE UPDATES, 2024, 76
  • [10] Breaking through therapeutic barriers: Insights into CDK4/6 inhibition resistance in hormone receptor-positive metastatic breast cancer
    Zheng, Yang
    Zhang, Zeyuan
    Li, Dan
    Huang, Rong
    Ning, Shipeng
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (05):
12345